. Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene. Cell Rep. 2021 Feb 2;34(5):108730. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.